These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8578513)

  • 1. Issues in the development of thrombin receptor antagonists.
    Brass LF
    Thromb Haemost; 1995 Jul; 74(1):499-505. PubMed ID: 8578513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin receptors: turning them off after turning them on.
    Brass LF; Ahuja M; Belmonte E; Blanchard N; Pizarro S; Tarver A; Hoxie JA
    Semin Hematol; 1994 Jul; 31(3):251-60. PubMed ID: 7973781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling through G proteins and G protein-coupled receptors during platelet activation.
    Brass LF; Hoxie JA; Manning DR
    Thromb Haemost; 1993 Jul; 70(1):217-23. PubMed ID: 8236108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual thrombin receptor system for platelet activation.
    Kahn ML; Zheng YW; Huang W; Bigornia V; Zeng D; Moff S; Farese RV; Tam C; Coughlin SR
    Nature; 1998 Aug; 394(6694):690-4. PubMed ID: 9716134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptor 3 is a second thrombin receptor in humans.
    Ishihara H; Connolly AJ; Zeng D; Kahn ML; Zheng YW; Timmons C; Tram T; Coughlin SR
    Nature; 1997 Apr; 386(6624):502-6. PubMed ID: 9087410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
    Hammes SR; Coughlin SR
    Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of a peptide antagonist to the thrombin receptor using phage display.
    Doorbar J; Winter G
    J Mol Biol; 1994 Dec; 244(4):361-9. PubMed ID: 7990127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAR3 is a cofactor for PAR4 activation by thrombin.
    Nakanishi-Matsui M; Zheng YW; Sulciner DJ; Weiss EJ; Ludeman MJ; Coughlin SR
    Nature; 2000 Apr; 404(6778):609-13. PubMed ID: 10766244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation.
    Covic L; Misra M; Badar J; Singh C; Kuliopulos A
    Nat Med; 2002 Oct; 8(10):1161-5. PubMed ID: 12357249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
    Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
    Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of the thrombin receptor (PAR-1) N-terminus from the surface of human platelets activated by thrombin.
    Ramachandran R; Klufas AS; Molino M; Ahuja M; Hoxie JA; Brass LF
    Thromb Haemost; 1997 Sep; 78(3):1119-24. PubMed ID: 9308764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the thrombin receptor in development and evidence for a second receptor.
    Connolly AJ; Ishihara H; Kahn ML; Farese RV; Coughlin SR
    Nature; 1996 Jun; 381(6582):516-9. PubMed ID: 8632823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin receptor structure and function.
    Coughlin SR
    Thromb Haemost; 1993 Jul; 70(1):184-7. PubMed ID: 8236100
    [No Abstract]   [Full Text] [Related]  

  • 15. Protease activated receptors: theme and variations.
    O'Brien PJ; Molino M; Kahn M; Brass LF
    Oncogene; 2001 Mar; 20(13):1570-81. PubMed ID: 11313904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist receptors and G proteins as mediators of platelet activation.
    Brass LF; Hoxie JA; Kieber-Emmons T; Manning DR; Poncz M; Woolkalis M
    Adv Exp Med Biol; 1993; 344():17-36. PubMed ID: 8209785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombin induced tumour growth - pharmacological control].
    Nowak G; Lopez M; Zieger M
    Hamostaseologie; 2007 May; 27(2):105-10. PubMed ID: 17479173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional tethered ligand thrombin receptor is present on human hematopoietic progenitor cells.
    DiCuccio MN; Shami P; Hoffman M
    Exp Hematol; 1996 Jul; 24(8):914-8. PubMed ID: 8690050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling pathways of the thrombin receptor.
    Van Obberghen-Schilling E; Pouysségur J
    Thromb Haemost; 1993 Jul; 70(1):163-7. PubMed ID: 8236094
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombin receptor antagonists as novel therapeutic targets.
    Chackalamannil S
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):417-27. PubMed ID: 11727307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.